Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS)

Thorax

Volumn 58, Issue 8, 2003, Pages 686-689

  Chan, J W M ^a,b   Ng, C K ^b   Chan, Y H ^b   Mok, T Y W ^a   Lee, S ^b   Chu, S Y Y ^b   Law, W L ^b   Lee, M P ^b   Li, P C K ^b  

^a QUEEN ELIZABETH HOSPITAL   (Hong Kong)

^b KOWLOON HOSPITAL   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; COMORBIDITY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEATH; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HEART DISEASE; HONG KONG; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; INFECTION RISK; INTENSIVE CARE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; PNEUMONIA; PRIORITY JOURNAL; SEVERE ACUTE RESPIRATORY SYNDROME; STATISTICAL SIGNIFICANCE;

ADULT; AGED; FEMALE; HONG KONG; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK FACTORS; SEVERE ACUTE RESPIRATORY SYNDROME; SURVIVAL ANALYSIS; SURVIVAL RATE;

EID: 0041352912     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thorax.58.8.686     Document Type: Article

References (19)

1. Ksiazek TG, Erdman D, Goldsmith CS, et al. A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med 2003;348:1953-66.
2. Drosten C, Gunther S, Preiser W, et al. Identification of a novel virus in patients with severe acute respiratory syndrome. N Engl J Med 2003;348:1967-76.
3. Peiris JSM, Lai ST, Poon LLM, et al. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet 2003;361:1319-25.
4. Tsang KW, Ho PL, Ooi GC, et al. A cluster of cases of severe acute respiratory syndrome in Hong Kong. N Engl J Med 2003;348:1977-85.
5. Lee N, Hui D, Wu A, et al. A major severe outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med 2003;348:1986-94.
6. Booth CM, Matuka LM, Tomlinson GA, et al. Clinical features and short-term outcomes of 144 patients with SARS in the Greater Toronto area. JAMA 2003;289:2801-9.
7. Peiris JSM, Chu CM, Cheng VCC, et al. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet 2003;361:1767-72.
8. Hospital Authority of Hong Kong. HA guidelines on severe acute respiratory syndrome. Available at http://www.ha.org.hk/sars/guidelines/index.html (accessed 10 May 2003).
9. World Health Organisation. Case definitions for surveillance of severe acute respiratory syndrome (SARS). Available at http://who.int/csr/sars/casedefinition/en (accessed 10 May 2003).
10. So LKY, Lau ACW, Yam LYC, et al. Development of a standard treatment protocol for severe acute respiratory syndrome. Lancet 2003;361:1615-7.
11. Donnelly CA, Ghani AC, Leung GM, et al. Epidemiological determinants of spread of casual agent of severe acute respiratory syndrome in Hong Kong. Lancet 2003;361:1761-6.
12. Niederman MS, Mandell LA, Anzueto A, et al. American Thoracic Society guidelines for the management of adults with communiy-acquired pneumonia. Am J Respir Crit Care Med 2001;163:1730-54.
13. Fine MJ, Smith MA, Carson CA, et al. Prognosis and outcomes of patients with community-acquired pneumonia: a meta-analysis. JAMA 1996;275:134-41.
14. Rello J, Quintana E, Ausina V, et al. Risk factors for Staphylococcus aureus nosocomial pneumonia in critically ill patients. Am Rev Respir Dis 1990;142:1320-4.
15. Centres of Disease Control and Prevention. Severe acute respiratory syndrome and coronavirus testing-United States, 2003. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5214a1.htm. (accessed 10 May 2003).
16. Oba Y, Lee N, Sung J. The use of corticosteroids in SARS. N Engl J Med 2003;348:2034-5.
17. Meduri GU, Headley AS, Golden E, et al. Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial. JAMA 1998;280:159-65.
18. Van Woensel JBM, Van Aalderen WMC, de Weerd W, et al. Dexamethasone for treatment of patients mechanically ventilated for lower respiratory tract infection caused by respiratory syncytial virus. Thorax 2003;58:383-7.
19. Koren G, King S, Knowles S, et al. Ribavirin in the treatment of SARS: a new trick for an old drug? Can Med Assoc J 2003;168:1289-92.